These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12444967)

  • 1. Site-specific modification of functional groups in genomic hepatitis delta virus (HDV) ribozyme.
    Nishikawa F; Shirai M; Nishikawa S
    Eur J Biochem; 2002 Dec; 269(23):5792-803. PubMed ID: 12444967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of short pseudoknot base pairs between two single-stranded regions of HDV ribozyme.
    Nishikawa F; Shirai M; Nishikawa S
    Nucleic Acids Symp Ser; 1999; (42):287-8. PubMed ID: 10780492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for canonical base pairing in the short pseudoknot structure of genomic hepatitis delta virus ribozyme.
    Nishikawa F; Nishikawa S
    Nucleic Acids Res; 2000 Feb; 28(4):925-31. PubMed ID: 10648784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro selection analysis of trans-acting HDV ribozyme.
    Nishikawa F; Chiba A; Shirai M; Fauzi H; Taira K; Kumar PK; Nishikawa S
    Nucleic Acids Symp Ser; 1995; (34):115-6. PubMed ID: 8841579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terbium-mediated footprinting probes a catalytic conformational switch in the antigenomic hepatitis delta virus ribozyme.
    Harris DA; Tinsley RA; Walter NG
    J Mol Biol; 2004 Aug; 341(2):389-403. PubMed ID: 15276831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nested double pseudoknot is required for self-cleavage activity of both the genomic and antigenomic hepatitis delta virus ribozymes.
    Wadkins TS; Perrotta AT; Ferré-D'Amaré AR; Doudna JA; Been MD
    RNA; 1999 Jun; 5(6):720-7. PubMed ID: 10376872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constructing an efficient trans-acting genomic HDV ribozyme.
    Kawakami J; Yuda K; Suh YA; Kumar PK; Nishikawa F; Maeda H; Taira K; Ohtsuka E; Nishikawa S
    FEBS Lett; 1996 Sep; 394(2):132-6. PubMed ID: 8843150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three-dimensional model of hepatitis delta virus ribozyme based on biochemical and mutational analyses.
    Tanner NK; Schaff S; Thill G; Petit-Koskas E; Crain-Denoyelle AM; Westhof E
    Curr Biol; 1994 Jun; 4(6):488-98. PubMed ID: 7922369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed analysis of base preferences at the cleavage site of a trans-acting HDV ribozyme: a mutation that changes cleavage site specificity.
    Nishikawa F; Fauzi H; Nishikawa S
    Nucleic Acids Res; 1997 Apr; 25(8):1605-10. PubMed ID: 9092669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of antigenomic hepatitis delta virus ribozyme cis- and trans- analogs.
    Savochkina L; Alekseenkova V; Belyanko T; Lukin M; Beabealashvilli R
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):935-42. PubMed ID: 15560085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of an extra substrate binding site and partial destabilization of stem structures in HDV ribozyme give rise to high sequence-specificity for its target RNA.
    Hori T; Guo F; Uesugi S
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):489-501. PubMed ID: 16838841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR analysis of tertiary interactions in HDV ribozymes.
    Tanaka Y; Hori T; Tagaya M; Katahira M; Nishikawa F; Sakamoto T; Kurihara Y; Nishikawa S; Uesugi S
    Nucleic Acids Symp Ser; 2000; (44):285-6. PubMed ID: 12903380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium dependence of the amplified conformational switch in the trans-acting hepatitis delta virus ribozyme.
    Tinsley RA; Harris DA; Walter NG
    Biochemistry; 2004 Jul; 43(28):8935-45. PubMed ID: 15248751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication.
    Jeng KS; Daniel A; Lai MM
    J Virol; 1996 Apr; 70(4):2403-10. PubMed ID: 8642668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of the P1.1 pseudoknot is critical for both the cleavage activity and substrate specificity of an antigenomic trans-acting hepatitis delta ribozyme.
    Deschênes P; Ouellet J; Perreault J; Perreault JP
    Nucleic Acids Res; 2003 Apr; 31(8):2087-96. PubMed ID: 12682359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pK(a) perturbation in genomic Hepatitis Delta Virus ribozyme catalysis evidenced by nucleotide analogue interference mapping.
    Oyelere AK; Kardon JR; Strobel SA
    Biochemistry; 2002 Mar; 41(11):3667-75. PubMed ID: 11888283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 1.9 A crystal structure of the HDV ribozyme precleavage suggests both Lewis acid and general acid mechanisms contribute to phosphodiester cleavage.
    Chen JH; Yajima R; Chadalavada DM; Chase E; Bevilacqua PC; Golden BL
    Biochemistry; 2010 Aug; 49(31):6508-18. PubMed ID: 20677830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection in vitro of trans-acting genomic human hepatitis delta virus (HDV) ribozymes.
    Nishikawa F; Kawakami J; Chiba A; Shirai M; Kumar PK; Nishikawa S
    Eur J Biochem; 1996 May; 237(3):712-8. PubMed ID: 8647117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and properties of trans-acting HDV ribozymes with extended substrate recognition regions.
    Hori T; Guo F; Tanaka Y; Uesugi S
    Nucleic Acids Res Suppl; 2001; (1):201-2. PubMed ID: 12836334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wobble pairs of the HDV ribozyme play specific roles in stabilization of active site dynamics.
    Sripathi KN; Banáš P; Réblová K; Šponer J; Otyepka M; Walter NG
    Phys Chem Chem Phys; 2015 Feb; 17(8):5887-900. PubMed ID: 25631765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.